Dabigatran Impurity 21 | CAS 255706-13-9 - Request Quote
Dabigatran Impurity 21
| SZ CAT No: | SZ-D012127 |
| CAS No | 255706-13-9 |
| Mol.F. | C14H21N3O2 |
| Mol.Wt. | 263.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 21 is chemically (1-Amino-1-(4-amino-phenyl)-meth-(Z)-ylidene)-carbamic acid hexyl ester. Dabigatran Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 255706-13-9
Purchase 255706-13-9
Order 255706-13-9
Enquire 255706-13-9
price of 255706-13-9
255706-13-9 Supplier
255706-13-9 Manufacturer
255706-13-9 Exporter
buy high quality Dabigatran Impurity 21
Purchase Dabigatran Impurity 21
Dabigatran Impurity 21 suppliers
Dabigatran Impurity 21 manufacturers
Dabigatran Impurity 21 price
Order Dabigatran Impurity 21
Enquire Dabigatran Impurity 21
Dabigatran Impurity 21 cost
Dabigatran Impurity 21 Supplier
Dabigatran Impurity 21 Distributor
Dabigatran Impurity 21 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 21 for ANDA Filing
Dabigatran Impurity 21 for Forced Degradation Studies
Dabigatran Impurity 21 Identification Standards
Dabigatran Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.